Epidemiology and management of chronic constipation in elderly patients

Clinical Interventions in Aging

Volumn 10, Issue , 2015, Pages 919-930

  Roque, Maria Vazquez ^a   Bouras, Ernest P ^a  

^a MAYO CLINIC   (United States)

Author keywords

Constipation; Elderly; Pelvic floor dysfunction

Indexed keywords

BISACODYL; BULKING AGENT; CHLORIDE CHANNEL STIMULATING AGENT; CISAPRIDE; ENEMA; GLYCEROL; GUANYLATE CYCLASE ACTIVATOR; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; PHOSPHATE ENEMA; PROKINETIC AGENT; PRUCALOPRIDE; SEROTONIN AGONIST; SOAPSUD ENEMA; TEGASEROD; UNCLASSIFIED DRUG; GASTROINTESTINAL AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; AGED; AGING; ALLERGIC REACTION; BLOATING; BLOOD ANALYSIS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC CONSTIPATION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COLITIS; COLON RESECTION; COLON TRANSIT; DIARRHEA; DIETARY FIBER; DIGESTIVE SYSTEM EXAMINATION; DIGESTIVE TRACT PARAMETERS; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; ELDERLY CARE; ELECTROLYTE DISTURBANCE; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; FLUID INTAKE; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HYPERPHOSPHATEMIA; ILEORECTAL ANASTOMOSIS; INCONTINENCE; INTESTINE INNERVATION; INTESTINE OBSTRUCTION; LIVER TOXICITY; MEDICAL HISTORY; NAUSEA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PELVIC FLOOR DISORDER; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PREVALENCE; PSYCHOSOCIAL DISORDER; QT PROLONGATION; QUALITY OF LIFE; RECTUM DISEASE; RECTUM EXAMINATION; RECTUM MUCOSAL DAMAGE; REVIEW; SACRAL NERVE STIMULATION; TREATMENT INDICATION; URINARY DYSFUNCTION; VULNERABLE POPULATION; ABDOMINAL SURGERY; CHRONIC DISEASE; CONSTIPATION; GASTROINTESTINAL TRANSIT; PELVIC FLOOR DISORDERS; PHYSIOLOGY; PHYSIOTHERAPY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE;

AGED; AGING; CATHARTICS; CHRONIC DISEASE; CONSTIPATION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; LAXATIVES; PELVIC FLOOR DISORDERS; PHYSICAL EXAMINATION; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84935909403     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S54304     Document Type: Review

References (114)

1. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99(4):750-759.
2. Bharucha AE, Pemberton JH, Locke GR. American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218-238.
3. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007;26(11-12):1521-1528.
4. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91(1):19-25.
5. Wald A, Scarpignato C, Mueller-Lissner S, et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008;28(7):917-930.
6. Longstreth GF. Functional bowel disorders: functional constipation. In: Drossman DA, editor. The Functional Gastrointestinal Disorders. 3rd ed. Lawrence, KS: Allen Press; 2006:515-523.
7. Whitehead WE, Drinkwater D, Cheskin LJ, Heller BR, Schuster MM. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc. 1989;37(5):423-429.
8. Donald IP, Smith RG, Cruikshank JG, Elton RA, Stoddart ME. A study of constipation in the elderly living at home. Gerontology. 1985;31(2):112-118.
9. Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med. 1996;156(3):315-320.
10. Harari D, Gurwitz JH, Avorn J, Choodnovskiy I, Minaker KL. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc. 1994;42(9):947-952.
11. Primrose WR, Capewell AE, Simpson GK, Smith RG. Prescribing patterns observed in registered nursing homes and long-stay geriatric wards. Age Ageing. 1987;16(1):25-28.
12. Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989;34(4):606-611.
13. Bongers ME, Benninga MA, Maurice-Stam H, Grootenhuis MA. Health-related quality of life in young adults with symptoms of constipation continuing from childhood into adulthood. Health Qual Life Outcomes. 2009;7:20.
14. Wang JP, Duan LP, Ye HJ, Wu ZG, Zou B. [Assessment of psychological status and quality of life in patients with functional constipation]. Zhonghua Nei Ke Za Zhi. 2008;47(6):460-463. Chinese.
15. Costilla VC, Foxx-Orenstein AE. Constipation in adults: diagnosis and management. Curr Treat Options Gastroenterol. 2014;12(3):310-321.
16. Costilla VC, Foxx-Orenstein AE. Constipation: understanding mechanisms and management. Clin Geriatr Med. 2014;30(1):107-115.
17. Bannister JJ, Abouzekry L, Read NW. Effect of aging on anorectal function. Gut. 1987;28(3):353-357.
18. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000;48(9):1142-1150.
19. Laurberg S, Swash M. Effects of aging on the anorectal sphincters and their innervation. Dis Colon Rectum. 1989;32(9):737-742.
20. Yu SW, Rao SS. Anorectal physiology and pathophysiology in the elderly. Clin Geriatr Med. 2014;30(1):95-106.
21. Hanani M, Fellig Y, Udassin R, Freund HR. Age-related changes in the morphology of the myenteric plexus of the human colon. Auton Neurosci. 2004;113(1-2):71-78.
22. Koch TR, Carney JA, Go VL, Szurszewski JH. Inhibitory neuropeptides and intrinsic inhibitory innervation of descending human colon. Dig Dis Sci. 1991;36(6):712-718.
23. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009;21(7):746-e46.
24. Lagier E, Delvaux M, Vellas B, et al. Influence of age on rectal tone and sensitivity to distension in healthy subjects. Neurogastroenterol Motil. 1999;11(2):101-107.
25. Saffrey MJ. Ageing of the enteric nervous system. Mech Ageing Dev. 2004;125(12):899-906.
26. Gomez-Pinilla PJ, Gibbons SJ, Sarr MG, et al. Changes in interstitial cells of cajal with age in the human stomach and colon. Neurogastroenterol Motil. 2011;23(1):36-44.
27. Singh J, Kumar S, Krishna CV, Rattan S. Aging-associated oxidative stress leads to decrease in IAS tone via RhoA/ROCK downregulation. Am J Physiol Gastrointest Liver Physiol. 2014;306(11):G983-G991.
28. Lewicky-Gaupp C, Hamilton Q, Ashton-Miller J, Huebner M, DeLancey JO, Fenner DE. Anal sphincter structure and function relationships in aging and fecal incontinence. Am J Obstet Gynecol. 2009;200(5):559.e1-e559.e5.
29. Gundling F, Seidl H, Scalercio N, Schmidt T, Schepp W, Pehl C. Influence of gender and age on anorectal function: normal values from anorectal manometry in a large caucasian population. Digestion. 2010;81(4):207-213.
30. Rao SS. Dyssynergic defecation. Gastroenterol Clin North Am. 2001;30(1):97-114.
31. Schey R, Cromwell J, Rao SS. Medical and surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol. 2012;107(11):1624-1633; quiz p.1634.
32. Loening-Baucke V, Anuras S. Effects of age and sex on anorectal manometry. Am J Gastroenterol. 1985;80(1):50-53.
33. Loening-Baucke V, Anuras S. Anorectal manometry in healthy elderly subjects. J Am Geriatr Soc. 1984;32(9):636-639.
34. McHugh SM, Diamant NE. Effect of age, gender, and parity on anal canal pressures. Contribution of impaired anal sphincter function to fecal incontinence. Dig Dis Sci. 1987;32(7):726-736.
35. Orr WC, Chen CL. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol Gastrointest Liver Physiol. 2002;283(6):G1226-G1231.
36. Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004;33(2):154-159.
37. Melkersson M, Andersson H, Bosaeus I, Falkheden T. Intestinal transit time in constipated and non-constipated geriatric patients. Scand J Gastroenterol. 1983;18(5):593-597.
38. Wiskur B, Greenwood-Van Meerveld B. The aging colon: the role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep. 2010;12(6):507-512.
39. Evans JM, Fleming KC, Talley NJ, Schleck CD, Zinsmeister AR, Melton LJ. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc. 1998;46(1):83-87.
40. Meier R, Beglinger C, Dederding JP, et al. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil. 1995;7(4):235-238.
41. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis. 2007;25(2):112-117.
42. Nullens S, Nelsen T, Camilleri M, et al. Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut. 2012;61(8):1132-1139.
43. Shin A, Camilleri M, Nadeau A, et al. Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil. 2013;25(6):502-508.
44. Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with severe idiopathic constipation. Gastroenterology. 1989;97(4):932-937.
45. Merkel IS, Locher J, Burgio K, Towers A, Wald A. Physiologic and psychologic characteristics of an elderly population with chronic constipation. Am J Gastroenterol. 1993;88(11):1854-1859.
46. Towers AL, Burgio KL, Locher JL, Merkel IS, Safaeian M, Wald A. Constipation in the elderly: influence of dietary, psychological, and physiological factors. J Am Geriatr Soc. 1994;42(7):701-706.
47. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97(8):1986-1993.
48. Nehra V, Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol. 2000;95(7):1755-1758.
49. Rao SS, Tuteja AK, Vellema T, Kempf J, Stessman M. Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol. 2004;38(8):680-685.
50. Talley NJ, O’Keefe EA, Zinsmeister AR, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992;102(3):895-901.
51. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349(14):1360-1368.
52. Harari D, Gurwitz JH, Avorn J, Bohn R, Minaker KL. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med. 1997;12(1):63-66.
53. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993;105(3):781-790.
54. Rao SS, Ozturk R, Stessman M. Investigation of the pathophysiology of fecal seepage. Am J Gastroenterol. 2004;99(11):2204-2209.
55. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569-1580.
56. Locke GR 3rd, Zinsmeister AR, Fett SL, Melton LJ 3rd, Talley NJ. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17(1):29-34.
57. Kolar GJ, Camilleri M, Burton D, Nadeau A, Zinsmeister AR. Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice. Neurogastroenterol Motil. 2014;26(1):131-138.
58. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008;103(4):820-822.
59. Tantiphlachiva K, Rao P, Attaluri A, Rao SS. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol. 2010;8(11):955-960.
60. Patriquin H, Martelli H, Devroede G. Barium enema in chronic constipation: is it meaningful? Gastroenterology. 1978;75(4):619-622.
61. Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc. 2002;56(3):325-332.
62. Rao SS, Singh S. Clinical utility of colonic and anorectal manometry in chronic constipation. J Clin Gastroenterol. 2010;44(9):597-609.
63. Lee BE, Kim GH. How to perform and interpret balloon expulsion test. J Neurogastroenterol Motil. 2014;20(3):407-409.
64. Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100(7):1605-1615.
65. Fletcher JG, Busse RF, Riederer SJ, et al. Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol. 2003;98(2):399-411.
66. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology. 1987;92(1):40-47.
67. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radioopaque markers. Gut. 1969;10(10):842-847.
68. Stivland T, Camilleri M, Vassallo M, et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology. 1991;101(1):107-115.
69. Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8-23.
70. Lee YY, Erdogan A, Rao SS. How to assess regional and whole gut transit time with wireless motility capsule. J Neurogastroenterol Motil. 2014;20(2):265-270.
71. Rao SS, Coss-Adame E, Valestin J, Mysore K. Evaluation of constipation in older adults: radioopaque markers (ROMs) versus wireless motility capsule (WMC). Arch Gerontol Geriatr. 2012;55(2):289-294.
72. Bouras EP, Tangalos EG. Chronic Constipation in the Elderly. Gastroenterology Clinics. 2009;38(3):463-480.
73. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011;33(8):895-901.
74. Ford AC, Moayyedi P, Lacy BE, et al; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl 1):S2-S26; quiz 27.
75. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(Suppl 1):S5-S21.
76. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209-218.
77. Wald A. Is chronic use of stimulant laxatives harmful to the colon? J Clin Gastroenterol. 2003;36(5):386-389.
78. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100(1):232-242.
79. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002;47(10):2222-2230.
80. Nyberg C, Hendel J, Nielsen OH. The safety of osmotically acting cathartics in colonic cleansing. Nat Rev Gastroenterol Hepatol. 2010;7(10):557-564.
81. Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100(4):936-971.
82. Castle SC, Cantrell M, Israel DS, Samuelson MJ. Constipation prevention: empiric use of stool softeners questioned. Geriatrics. 1991;46(11):84-86.
83. Leung FW, Rao SS. Approach to fecal incontinence and constipation in older hospitalized patients. Hosp Pract (1995). 2011;39(1):97-104.
84. Sédaba B, Azanza JR, Campanero MA, Garcia-Quetglas E, Muñoz MJ, Marco S. Effects of a 250-mL enema containing sodium phosphate on electrolyte concentrations in healthy volunteers: An open-label, randomized, controlled, two-period, crossover clinical trial. Curr Ther Res Clin Exp. 2006;67(5):334-349.
85. Schmelzer M, Schiller LR, Meyer R, Rugari SM, Case P. Safety and effectiveness of large-volume enema solutions. Appl Nurs Res. 2004;17(4):265-274.
86. Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol. 2004;2(9):796-805.
87. Kamm MA, Müller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005;100(2):362-372.
88. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120(2):354-360.
89. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008;358(22):2344-2354.
90. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009;21(12):1256-e117.
91. Drossman DA, Chey WD, Johanson JF, et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther. 2009;29(3):329-341.
92. Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2008;27(8):685-696.
93. Johanson JF, Morton D, Geenen J, Ueno R. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 2008;103(1):170-177.
94. Bharucha AE, Linden DR. Linaclotide - a secretagogue and antihyperalgesic agent - what next? Neurogastroenterol Motil. 2010;22(3): 227-231.
95. Vazquez Roque M, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol. 2011;5(3):301-310.
96. Bharucha AE, Rao SS. An update on anorectal disorders for gastroenterologists. Gastroenterology. 2014;146(1):37-45.e2.
97. Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K. Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol. 2010;105(4):890-896.
98. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657-664.
99. Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5(3):331-338.
100. Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50(4):428-441.
101. Simón MA, Bueno AM. Behavioural treatment of the dyssynergic defecation in chronically constipated elderly patients: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2009;34(4):273-277.
102. Hassan I, Pemberton JH, Young-Fadok TM, et al. Ileorectal anastomosis for slow transit constipation: long-term functional and quality of life results. J Gastrointest Surg. 2006;10(10):1330-1336; discussion 1336-1337.
103. Gladman MA, Knowles CH. Surgical treatment of patients with constipation and fecal incontinence. Gastroenterol Clin North Am. 2008;37(3):605-625.
104. Knowles CH, Scott M, Lunniss PJ. Outcome of colectomy for slow transit constipation. Ann Surg. 1999;230(5):627-638.
105. Rotholtz NA, Wexner SD. Surgical treatment of constipation and fecal incontinence. Gastroenterol Clin North Am. 2001;30(1):131-166.
106. Kamm MA, Hawley PR, Lennard-Jones JE. Lateral division of the puborectalis muscle in the management of severe constipation. Br J Surg. 1988;75(7):661-663.
107. Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010;59(3):333-340.
108. Maria G, Cadeddu F, Brandara F, Marniga G, Brisinda G. Experience with type A botulinum toxin for treatment of outlet-type constipation. Am J Gastroenterol. 2006;101(11):2570-2575.
109. Faried M, El Nakeeb A, Youssef M, Omar W, El Monem HA. Comparative study between surgical and non-surgical treatment of anismus in patients with symptoms of obstructed defecation: a prospective randomized study. J Gastrointest Surg. 2010;14(8):1235-1243.
110. Verne GN, Davis RH, Robinson ME, Gordon JM, Eaker EY, Sninksy CA. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol. 2003;98(5):1112-1116.
111. Soffer EE, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci. 1994;39(5): 929-933.
112. Roarty TP, Weber F, Soykan I, McCallum RW. Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment Pharmacol Ther. 1997;11(6):1059-1066.
113. Ghoshal UC, Srivastava D, Verma A, Misra A. Slow transit constipation associated with excess methane production and its improvement following rifaximin therapy: a case report. J Neurogastroenterol Motil. 2011;17(2):185-188.
114. Attaluri A, Jackson M, Valestin J, Rao SS. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol. 2010;105(6):1407-1411